Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Respiratory and Critical Care Medicine|September 13, 2023
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER TrialPaul McNally, Karen Lester, Gavin Stone, et al.Respiratory Research|August 11, 2023
The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world settingPaul McNally, Barry Linnane, Michael Williamson, et al.The Pediatric Infectious Disease Journal|September 18, 2015
Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective StudyMargaret Sheridan-Pereira, Joan Murphy, Julie Sloan, et al.Frontiers in Pediatrics|August 26, 2021
Multi-Organ Dysfunction in Cerebral PalsyJohn Allen, Zunera Zareen, Samantha Doyle, et al.Pediatric Pulmonology|June 12, 2026
Performance Evaluation of a Novel Cystic Fibrosis Caregiver Burden Measure Demonstrates Significant Challenges for Parents of Children With CF During the Early Years: The Irish Comparative Outcomes Study (ICOS)Rini Bhatnagar, Nancy Bhardwaj, Gwinyai Masukume, et al.Annals of the American Thoracic Society|April 13, 2026
Impact of two years of treatment with Elexacaftor/Tezacaftor/Ivacaftor on longitudinal changes in structural lung disease in people with Cystic Fibrosis - Results from the RECOVER trialPaul McNally, Karen Lester, Rachel Cregan, et al.ERJ Open Research|April 27, 2023
Diffuse alveolar haemorrhage in children: an international multicentre studyAstrid Madsen Ring, Nicolaus Schwerk, Nural Kiper, et al.ERJ Open Research|August 19, 2021
Biologicals in childhood severe asthma: the European PERMEABLE survey on the status quoElisangela Santos-Valente, Heike Buntrock-Döpke, Rola Abou Taam, et al.Pageof 3